Learn More
Apexbio Technology LLC Lumiracoxib 220991-20-8 250mg

Supplier: Apexbio Technology LLC B1458250
Lumiracoxib (CAS 220991-20-8) is a small molecule that selectively inhibits cyclooxygenase-2 (COX-2) an enzyme involved in prostaglandin synthesis and inflammatory signaling In biochemical assays lumiracoxib demonstrates an IC of 0 14 M and a K of 0 06 M for COX-2 with a selectivity ratio of 515-fold over cyclooxygenase-1 (COX-1) This high degree of isoform selectivity makes lumiracoxib a valuable tool for investigating the specific roles of COX-2 in inflammation and for exploring COX-2 targeted therapeutic strategies in inflammatory and pain-related disorders
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.